Biodoz Therapeutics Private Limited

Biodoz Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U52390TG2012PTC085063 Incorporated 27 December 2012 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹30 Lakh
▼ 17% YoY
Net profit · FY 2025
₹22,740
Net margin 0.8%
EBITDA · FY 2025
₹30,730
EBITDA margin 1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Biodoz Therapeutics Private Limited

Data last updated:

Biodoz Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 December 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U52390TG2012PTC085063. Its GSTIN is 36AAFCB4180Q1Z7 (Telangana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Padmaja Bundla and Venkat Kamalakar Bundla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.401 Millennium Square Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, India – 500037.

As per the financials filed for FY 2025, the company reported a revenue of ₹30 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹22,740 (net margin 0.8%) and EBITDA of ₹30,730 (EBITDA margin 1%). Revenue has declined at a compounded annual rate (CAGR) of 12% over five years.

Biodoz Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0002739). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U52390TG2012PTC085063
Registration Number 085063
Incorporation Date 27 December 2012
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0002739

CIN history

Biodoz Therapeutics has one previous CIN (Corporate Identification Number): U52390AP2012PTC085063. The current CIN is U52390TG2012PTC085063, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U52390TG2012PTC085063Current
U52390AP2012PTC085063Previous

Recognitions & Rankings of Biodoz Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-TS-02-0002739

Contact details

Biodoz Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H.No.401 Millennium Square Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, India – 500037
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Biodoz Therapeutics Private Limited, buy the company report.

Comprehensive company report
Biodoz Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Biodoz Therapeutics is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Biodoz Therapeutics Private Limited, buy the company report.

Financials of Biodoz Therapeutics Private Limited

FY 2025 filings available

Biodoz Therapeutics Private Limited reported revenue of ₹30 Lakh (down 17% YoY) for FY 2025.

Revenue · FY 2025
₹30 Lakh ▼ 17%
Net profit · FY 2025
₹22,740 margin 0.8%
EBITDA · FY 2025
₹30,730 margin 1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▼ 88%
3 years · compounded
▲ 30%
5 years · compounded
▲ 15%

Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 17% fall in the latest year. EBITDA fell 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹30,730
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22,740
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biodoz Therapeutics Private Limited, buy the company report.

Board of directors of Biodoz Therapeutics Private Limited

Biodoz Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Padmaja BundlaDirector27 Dec 201213 Years 10 MonthsCurrent
Venkat Kamalakar BundlaDirector27 Dec 201213 Years 10 MonthsCurrent

Auditor

Biodoz Therapeutics Private Limited is audited by VASANTHA RAO & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
VASANTHA RAO & ASSOCIATESFY 2020004548S

Shareholding

The shareholding of Biodoz Therapeutics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Biodoz Therapeutics Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Biodoz Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Biodoz Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAFCB4180Q1Z7TelanganaActive07 Nov 2017

To see the full GST registrations and return filing status of Biodoz Therapeutics Private Limited, buy the company report.

Recent activity

Biodoz Therapeutics Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Bhanu Teja Bulusu ceased to be Director on 01 Nov 2024.

AGM
Biodoz Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biodoz Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Bhanu Teja Bulusu ceased to be Director.
Ceased
Ramalakshmi Bulusu ceased to be Director.
Appointed
Padmaja Bundla was appointed as Director.
Appointed
Venkat Kamalakar Bundla was appointed as Director.
Incorporation
27 Dec 2012
Biodoz Therapeutics Private Limited was registered on 27 Dec 2012 with Roc Hyderabad & aged 13 years 10 months as per MCA records.

Frequently asked questions

Biodoz Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 December 2012 (14+ years old) and is registered under CIN U52390TG2012PTC085063.

Biodoz Therapeutics has 2 current directors:

The latest financial statements of Biodoz Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Biodoz Therapeutics is 36AAFCB4180Q1Z7, registered in Telangana.

The CIN (Corporate Identification Number) of Biodoz Therapeutics is U52390TG2012PTC085063. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Biodoz Therapeutics was incorporated on 27 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.

Bhanu Teja Bulusu ceased to be Director on 01 Nov 2024. Ramalakshmi Bulusu ceased to be Director on 01 Nov 2024. Padmaja Bundla was appointed as Director on 27 Dec 2012. Biodoz Therapeutics has 4 board changes on record in total.

Yes, Biodoz Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0002739).

The registered office of Biodoz Therapeutics is at H.No.401 Millennium Square Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, India – 500037.

Biodoz Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.